X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-24 | SLNO | Soleno Therapeutics Inc | Hirano Patricia C | SEE REMARKS | S - Sale+OE | $84.25 | -266 | 17,036 | -2% | -$22,411 | |||||
| M | 2025-06-17 | CBLL | Ceribell, Inc. | Robertson Rebecca B | Dir | S - Sale | $17.76 | -18,633 | 10,042 | -65% | -$330,961 | |||||
2025-06-16 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $22.23 | -711 | 78,721 | -1% | -$15,806 | ||||||
| D | 2025-06-16 | CBLL | Ceribell, Inc. | Robertson Rebecca B | Dir | S - Sale+OE | $17.14 | -20,000 | 28,675 | -41% | -$342,800 | |||||
2025-06-13 | IRIX | Iridex Corp | Moore William M | Dir | P - Purchase | $0.97 | +20,000 | 287,976 | +7% | +$19,372 | ||||||
2025-06-13 | IRIX | Iridex Corp | Mercer Patrick | Pres, CEO | P - Purchase | $0.96 | +250 | 386,730 | 0% | +$240 | ||||||
| M | 2025-06-11 | IRIX | Iridex Corp | Moore William M | Dir | P - Purchase | $0.97 | +30,000 | 267,976 | +13% | +$29,121 | |||||
2025-06-10 | BLFS | Biolife Solutions Inc | Casdin Partners Master Fund, L.P. | 10% | S - Sale | $23.80 | -1,000,000 | 7,707,165 | -11% | -$23,800,000 | ||||||
2025-06-10 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $23.70 | -362 | 134,922 | 0% | -$8,579 | ||||||
2025-06-10 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $23.70 | -637 | 353,118 | 0% | -$15,097 | ||||||
2025-06-10 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $23.70 | -1,042 | 186,685 | -1% | -$24,695 | ||||||
2025-06-10 | BLFS | Biolife Solutions Inc | Werner Sean | CTO | S - Sale | $23.70 | -65 | 27,610 | 0% | -$1,541 | ||||||
2025-06-10 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $23.70 | -235 | 79,432 | 0% | -$5,570 | ||||||
2025-06-10 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $23.70 | -320 | 194,996 | 0% | -$7,584 | ||||||
2025-06-11 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $0.97 | +245 | 15,245 | +2% | +$236 | ||||||
2025-06-09 | AXGN | Axogen, Inc. | Weiler Kathy Johnson | Dir | S - Sale | $10.61 | -4,073 | 6,580 | -38% | -$43,215 | ||||||
2025-06-09 | AXGN | Axogen, Inc. | Levine Alan M | Dir | S - Sale | $10.61 | -4,073 | 36,743 | -10% | -$43,215 | ||||||
2025-06-09 | AXGN | Axogen, Inc. | Wendell Amy McBride | Dir | S - Sale | $10.61 | -4,073 | 93,826 | -4% | -$43,215 | ||||||
2025-06-09 | AXGN | Axogen, Inc. | Burke William P. Mr. | Dir | S - Sale | $10.61 | -4,073 | 24,484 | -14% | -$43,215 | ||||||
2025-06-09 | AXGN | Axogen, Inc. | Neels Guido J | Dir | S - Sale | $10.61 | -4,073 | 86,743 | -4% | -$43,215 | ||||||
2025-06-09 | AXGN | Axogen, Inc. | Johnson John | Dir | S - Sale | $10.61 | -4,073 | 24,943 | -14% | -$43,215 | ||||||
| D | 2025-06-10 | AXGN | Axogen, Inc. | Tyndall Joseph A. | Dir | S - Sale+OE | $10.72 | -26,931 | 0 | -100% | -$288,700 | |||||
| M | 2025-06-09 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $0.98 | +835 | 15,000 | +6% | +$822 | |||||
2025-06-09 | TMDX | Transmedics Group, Inc. | Ranganath Anil P. | See remarks | S - Sale | $139.80 | -686 | 13,955 | -5% | -$95,903 | ||||||
2025-06-06 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $0.97 | +1,500 | 14,165 | +12% | +$1,455 | ||||||
| D | 2025-06-05 | ITGR | Integer Holdings Corp | Maxwell Martin C | Dir | S - Sale+OE | $120.56 | -8,720 | 22,170 | -28% | -$1,051,279 | |||||
| D | 2025-06-04 | ITGR | Integer Holdings Corp | Spence Donald J | Dir | S - Sale+OE | $120.38 | -14,739 | 18,781 | -44% | -$1,774,340 | |||||
| D | 2025-06-03 | CBLL | Ceribell, Inc. | Chao Xingjuan | Pres, CEO | S - Sale+OE | $17.00 | -25,000 | 1,145,110 | -2% | -$425,000 | |||||
| M | 2025-06-02 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.00 | +200 | 12,665 | +2% | +$199 | |||||
2024-01-25 | YBGJ | Yubo International Biotech Ltd | Boao Biotech Ltd | 10% | S - Sale | $0.30 | -5,040,140 | 19,927,660 | -20% | -$1,512,042 | ||||||
2024-07-15 | YBGJ | Yubo International Biotech Ltd | Wang Yang | CEO, 10% | S - Sale | $0.12 | -2,000,000 | 17,211,400 | -10% | -$240,000 | ||||||
2025-05-28 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $22.46 | -251 | 195,316 | 0% | -$5,637 | ||||||
2025-05-28 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $22.46 | -217 | 79,667 | 0% | -$4,874 | ||||||
2025-05-28 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $22.46 | -348 | 135,284 | 0% | -$7,816 | ||||||
2025-05-28 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $22.46 | -521 | 353,755 | 0% | -$11,702 | ||||||
2025-05-28 | BLFS | Biolife Solutions Inc | Werner Sean | CTO | S - Sale | $22.46 | -109 | 27,675 | 0% | -$2,448 | ||||||
2025-05-28 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $22.46 | -583 | 187,727 | 0% | -$13,094 | ||||||
2025-05-29 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $0.99 | +200 | 12,465 | +2% | +$197 | ||||||
| D | 2025-05-27 | TMDX | Transmedics Group, Inc. | Basile Edward M | Dir | S - Sale+OE | $126.45 | -5,000 | 2,866 | -64% | -$632,250 | |||||
2025-05-28 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $0.95 | +200 | 12,265 | +2% | +$190 | ||||||
2025-05-27 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.00 | +100 | 12,065 | +1% | +$100 | ||||||
2025-05-23 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.00 | +100 | 11,965 | +1% | +$100 | ||||||
2025-05-23 | ECOR | Electrocore, Inc. | Gandolfo John P | Dir | P - Purchase | $5.01 | +1,800 | 69,087 | +3% | +$9,018 | ||||||
2025-05-23 | TMDX | Transmedics Group, Inc. | Weill David | Dir | S - Sale | $123.88 | -732 | 12,134 | -6% | -$90,680 | ||||||
| D | 2025-05-22 | AXGN | Axogen, Inc. | Tyndall Joseph A. | Dir | S - Sale+OE | $11.20 | -20,062 | 15,345 | -57% | -$224,694 | |||||
2025-05-19 | AXGN | Axogen, Inc. | Tyndall Joseph A. | Dir | S - Sale | $11.63 | -2,525 | 22,557 | -10% | -$29,366 | ||||||
2025-05-22 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.00 | +200 | 11,865 | +2% | +$201 | ||||||
| D | 2025-05-15 | CBLL | Ceribell, Inc. | Chao Xingjuan | Pres, CEO | S - Sale+OE | $16.96 | -25,000 | 1,145,110 | -2% | -$424,000 | |||||
| M | 2025-05-14 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.01 | +12,740 | 13,840,895 | 0% | +$12,867 | |||||
2025-05-16 | HYPR | Hyperfine, Inc. | Teisseyre Thomas | COO | S - Sale | $0.58 | -2,776 | 82,213 | -3% | -$1,610 | ||||||
2025-05-15 | OM | Outset Medical, Inc. | Trigg Leslie | Chair, CEO | S - Sale | $17.80 | -935 | 100,379 | -1% | -$16,643 | ||||||
2025-05-15 | OM | Outset Medical, Inc. | Nash Marc | SVP Operations, R, D | S - Sale | $17.82 | -252 | 13,465 | -2% | -$4,491 | ||||||
2025-05-15 | OM | Outset Medical, Inc. | Brottem John L. | GC | S - Sale | $17.82 | -396 | 11,273 | -3% | -$7,057 | ||||||
2025-05-15 | OM | Outset Medical, Inc. | Ahmed Nabeel | CFO | S - Sale | $17.81 | -584 | 16,096 | -4% | -$10,401 | ||||||
| M | 2025-05-14 | IRIX | Iridex Corp | Moore William M | Dir | P - Purchase | $1.09 | +17,500 | 237,976 | +8% | +$19,009 | |||||
2025-05-14 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.10 | +460 | 11,665 | +4% | +$506 | ||||||
| D | 2025-05-12 | MASI | Masimo Corp | Muhsin Bilal | COO | S - Sale+OE | $163.28 | -10,000 | 24,172 | -29% | -$1,632,781 | |||||
| D | 2025-05-09 | TMDX | Transmedics Group, Inc. | Basile Edward M | Dir | S - Sale+OE | $115.63 | -6,000 | 732 | -89% | -$693,780 | |||||
2025-05-13 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.11 | +1,305 | 11,205 | +13% | +$1,451 | ||||||
2025-05-12 | ECOR | Electrocore, Inc. | Errico Thomas J. | Dir | P - Purchase | $4.77 | +10,000 | 266,401 | +4% | +$47,735 | ||||||
2025-05-12 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.16 | +100 | 9,900 | +1% | +$116 | ||||||
2025-05-09 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.15 | +100 | 9,800 | +1% | +$115 | ||||||
2025-05-08 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.15 | +100 | 9,700 | +1% | +$115 | ||||||
2025-05-07 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.15 | +193 | 9,600 | +2% | +$222 | ||||||
2025-05-06 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.17 | +200 | 9,407 | +2% | +$235 | ||||||
2025-05-05 | CNMD | Conmed Corp | Farkas Charles | Dir | S - Sale | $56.94 | -4,000 | 16,346 | -20% | -$227,768 | ||||||
2025-05-05 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.19 | +200 | 9,207 | +2% | +$237 | ||||||
| D | 2025-05-01 | ITGR | Integer Holdings Corp | Dziedzic Joseph W | Pres, CEO | S - Sale+OE | $123.17 | -338,975 | 23,000 | -94% | -$41,751,433 | |||||
| M | 2025-04-28 | IRIX | Iridex Corp | Moore William M | Dir | P - Purchase | $1.21 | +20,000 | 220,476 | +10% | +$24,144 | |||||
2025-04-29 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.23 | +3,907 | 9,007 | +77% | +$4,807 | ||||||
2025-04-24 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.01 | +1,113 | 13,828,155 | 0% | +$1,124 | ||||||
2025-04-28 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.28 | +2,625 | 5,100 | +106% | +$3,363 | ||||||
| M | 2025-04-24 | IRIX | Iridex Corp | Mercer Patrick | Pres, CEO | P - Purchase | $1.29 | +7,546 | 400,790 | +2% | +$9,758 | |||||
2025-04-25 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.18 | +975 | 2,475 | +65% | +$1,151 | ||||||
2025-04-24 | IRIX | Iridex Corp | Shuda Scott | Dir | P - Purchase | $1.20 | +21,457 | 129,523 | +20% | +$25,748 | ||||||
| M | 2025-04-23 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.16 | +1,000 | 1,500 | +200% | +$1,155 | |||||
| M | 2025-04-22 | CBLL | Ceribell, Inc. | Chao Xingjuan | Pres, CEO | S - Sale | $15.11 | -15,928 | 1,096,239 | -1% | -$240,657 | |||||
2025-04-23 | IRIX | Iridex Corp | Huss Beverly A | Dir | P - Purchase | $1.22 | +25,900 | 92,639 | +39% | +$31,500 | ||||||
| M | 2025-04-21 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.01 | +1,812 | 13,827,042 | 0% | +$1,830 | |||||
| M | 2025-04-21 | IRIX | Iridex Corp | Moore William M | Dir | P - Purchase | $1.07 | +20,000 | 200,476 | +11% | +$21,371 | |||||
2025-04-21 | NRX | Neuraxis, Inc | Hannasch Brian | 10% | P - Purchase | $1.73 | +18,065 | 775,966 | +2% | +$31,251 | ||||||
2025-04-21 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.05 | +500 | 500 | New | +$525 | ||||||
| M | 2025-04-17 | CBLL | Ceribell, Inc. | Chao Xingjuan | Pres, CEO | S - Sale | $15.02 | -9,072 | 1,112,167 | -1% | -$136,295 | |||||
| DM | 2025-03-07 | GTHP | Guided Therapeutics Inc | Imhoff John E | Dir, 10% | P - Purchase | $0.10 | +1,263,355 | 17,992,380 | +8% | +$126,307 | |||||
| M | 2025-04-09 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.02 | +20,840 | 13,825,230 | 0% | +$21,234 | |||||
2025-04-09 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $20.11 | -932 | 188,310 | 0% | -$18,743 | ||||||
2025-04-09 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $20.11 | -569 | 309,007 | 0% | -$11,443 | ||||||
2025-04-09 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $20.11 | -210 | 79,884 | 0% | -$4,223 | ||||||
2025-04-09 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $20.11 | -324 | 135,632 | 0% | -$6,516 | ||||||
2025-04-09 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $20.11 | -286 | 195,567 | 0% | -$5,751 | ||||||
| D | 2025-04-09 | QTI | Qt Imaging Holdings, Inc. | Katz Avi S | COB | P - Purchase | $0.64 | +392,464 | 1,168,035 | +51% | +$250,000 | |||||
| D | 2025-04-09 | QTI | Qt Imaging Holdings, Inc. | Dinu Raluca | CEO | P - Purchase | $0.64 | +392,465 | 1,168,035 | +51% | +$250,000 | |||||
| M | 2025-04-04 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.00 | +205,482 | 18,603,590 | +1% | +$205,258 | |||||
| D | 2025-03-18 | GTHP | Guided Therapeutics Inc | James Michael C | Dir | P - Purchase | $0.10 | +412,945 | 525,717 | +366% | +$41,295 | |||||
| M | 2025-04-02 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.00 | +24,939 | 18,398,108 | 0% | +$24,959 | |||||
2025-04-01 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $22.66 | -5,771 | 80,094 | -7% | -$130,771 | ||||||
2025-04-01 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $22.66 | -8,902 | 135,956 | -6% | -$201,719 | ||||||
2025-04-01 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $22.66 | -25,687 | 189,242 | -12% | -$582,067 | ||||||
2025-04-01 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $22.66 | -7,869 | 195,853 | -4% | -$178,312 | ||||||
2025-04-01 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $22.66 | -10,589 | 309,576 | -3% | -$239,947 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |